368426-24-8

Basic information

• Product Name: Benzonitrile, 4-(azidomethyl)-3-fluoro-
• CAS NO: 368426-24-8
• Molecular Formula: C8H5FN4
• Molecular Weight: 176.153
• Mol File: 368426-24-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 4-(azidomethyl)-3-fluoro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-(azidomethyl)-3-fluoro-(368426-24-8)
• EPA Substance Registry System: Benzonitrile, 4-(azidomethyl)-3-fluoro-(368426-24-8)

Safety Data

• Hazardous Substances Data: 368426-24-8(Hazardous Substances Data)

Upstream product

• 219873-06-0 3-fluoro-4-(hydroxymethyl)benzonitrile 
• 170572-49-3 2-fluoro-4-cyanotoluene 
• 105942-09-4 4-(bromomethyl)-3-fluorobenzonitrile 
• 51436-99-8 2-fluoro-4-bromotoluene 

Downstream Products

• 701264-00-8 4-(aminomethyl)-3-fluorobenzonitrile 
• 368426-25-9 3-fluoro-4-(azidomethyl)-phenyl-N-hydroxyamidine 
• 368426-26-0 4-azidomethyl-3-fluoro-N-propoxy-benzamidine 
• 368426-27-1 4-aminomethyl-3-fluoro-N-propoxy-benzamidine 
• 368426-25-9 4-azidomethyl-3-fluoro-N-hydroxy-benzamidine 

Relevant articles and documents

NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS

There is provided compounds of formula I, [Chemical formula should be inserted here. Please see paper copy] wherein R1 to R4 , R41 to R46 and Z have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias

Non-covalent inhibitors of urokinase and blood vessel formation

Novel compounds having activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have P1 a group having an amidino or guanidino moiety or derivative thereof. These compounds are useful in vitro for monitoring plasminogen activator levels and in vivo in treatment of conditions which are ameliorated by inhibition of or decreased activity of urokinase and in treating pathologic conditions wherein blood vessel formation is related to a pathologic condition.

Non-covalent inhibitors of urokinase and blood vessel formation

Novel compounds having activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have Pi a group having an amidino or guanidino moiety or derivative thereof. These compounds are useful in vitro for monitoring plasminogen activator levels and in vivo in treatment of conditions which are ameliorated by inhibition of or decreased activity of urokinase and in treating pathologic conditions wherein blood vessel formation is related to a pathologic condition.